Thomas Trimarchi, President and CFO of BridgeBio Pharma, Inc., filed a Form 4 on November 17, 2026, disclosing a share withholding transaction on November 16, 2026, related to the vesting of restricted stock units.

Key Highlights

  • Reporting person: Thomas Trimarchi, President and CFO of BridgeBio Pharma, Inc.
  • Transaction date: November 16, 2026, coded "F" (shares withheld for taxes).
  • Shares withheld: 22,781 shares of Common Stock disposed of at $77.36 per share.
  • RSU vesting: The withholding arose from the vesting of 41,193 shares of Common Stock underlying Trimarchi's RSUs, according to the filing.
  • Remaining holdings: Trimarchi directly beneficially owned 313,748 shares of Common Stock following the transaction.

BridgeBio CFO Trimarchi Reports RSU Tax Withholding of 22,781 Shares

According to the Form 4 filed with the SEC on November 17, 2026, Thomas Trimarchi, serving as President and CFO of BridgeBio Pharma, Inc. (NASDAQ:BBIO), reported a single non-derivative transaction on November 16, 2026. The transaction code was "F," which the filing identifies as shares withheld to satisfy a tax obligation.

The filing states that 22,781 shares of the issuer's Common Stock were withheld at a price of $77.36 per share. Per the filing's footnote, this withholding "represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 41,193 shares of Common Stock underlying the Reporting Person's RSUs." Following the reported transaction, Trimarchi directly held 313,748 shares of Common Stock, as disclosed in the filing.

No derivative securities transactions were reported. The form was filed by one reporting person and was signed by Will Solis as Attorney-in-Fact on November 17, 2026. The filing does not indicate that the transaction was made pursuant to a Rule 10b5-1(c) plan, as the relevant checkbox was not marked.

What Was Disclosed

BridgeBio Pharma's President and CFO Thomas Trimarchi disclosed a tax-withholding transaction on November 16, 2026, in which 22,781 shares were withheld at $77.36 per share upon the vesting of 41,193 RSU shares, leaving him with 313,748 shares directly held.